ICM
ATRO icon

Invenomic Capital Management’s Astronics ATRO Stock Holding History

Invenomic Capital Management’s Portfolio ATRO Stock Details ATRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,089
Closed -$288K – 122
2020
Q4 		$288K Buy
+26,089
New +$214K 0.07% 118

Other funds holding ATRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Invenomic Capital Management's ATRO Position: Q1 2021 in Review

Invenomic Capital Management sold out of Astronics (ATRO) in Q1 2021, closing a stake of 26,089 shares — an estimated $288K sold.

Invenomic Capital Management first reported a position in ATRO in Q4 2020 and held it in 1 quarter. The position peaked at $288K in Q4 2020. 112 funds tracked by Wall St. Rank hold ATRO as of Q1 2021.

  • Invenomic Capital Management reported no remaining Astronics position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 26,089 Astronics shares in Q1 2021, an estimated $288K.
  • Invenomic Capital Management first reported a position in Astronics in Q4 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Astronics position peaked at $288K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held Astronics as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.